Mark Pollack to Alprazolam
This is a "connection" page, showing publications Mark Pollack has written about Alprazolam.
Connection Strength
1.015
-
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
Score: 0.376
-
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
Score: 0.123
-
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63.
Score: 0.118
-
Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
Score: 0.058
-
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 12:24-9.
Score: 0.049
-
Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
Score: 0.041
-
The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6.
Score: 0.032
-
Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
Score: 0.031
-
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
Score: 0.029
-
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76.
Score: 0.025
-
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990 Dec; 51 Suppl A:12-6.
Score: 0.024
-
Long-term management of panic disorder. J Clin Psychiatry. 1990 May; 51 Suppl:11-3; discussion 50-3.
Score: 0.024
-
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
Score: 0.020
-
Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
Score: 0.019
-
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005 Sep; 62(9):1022-30.
Score: 0.017
-
Clinical issues in the long-term treatment of panic disorder. J Clin Psychiatry. 1996; 57 Suppl 10:44-8; discussion 49-50.
Score: 0.009
-
Pattern of placebo response in panic disorder. Psychopharmacol Bull. 1995; 31(2):273-8.
Score: 0.008
-
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
Score: 0.007
-
Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989 Jun; 28(3):345-50.
Score: 0.006